Capricor Therapeutics CAPR Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's current ratio?
- Capricor Therapeutics (CAPR) reported current ratio of 8.4× in Q1 2026.
- How has Capricor Therapeutics's current ratio changed year-over-year?
- Capricor Therapeutics's current ratio increased by 28.5% year-over-year, from 6.5× to 8.4×.
- What is the long-term trend for Capricor Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Capricor Therapeutics's current ratio has grown at a -4.5% compound annual growth rate (CAGR), from 11.3× to 9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.